Brought to you by 
Human Longevity formed with $70mm in Series A money; $10mm added later
Mar 2014
Executive Summary
Newly formed drug/diagnostics developer Human Longevity Inc. (HLI) received $70mm in Series A money from investors including Malaysian billionaire Lim Kok Thay plus other high-net-worth individuals, and genome-sequencing system builder Illumina Inc.
Deal Industry
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
- Gene Therapy, Cell Therapy
-
Drug Discovery Tools
- In Vitro Diagnostics
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
- Services
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Human Longevity formed with $70mm in Series A money; $10mm added later
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice